TOFRANIL-PM |
017090 |
001 |
NDA |
IMIPRAMINE PAMOATE |
CAPSULE;ORAL |
EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
1973/03/11
|
Approved Prior to Jan 1, 1982
|
SPECGX LLC |
Discontinued |
TOFRANIL-PM |
017090 |
002 |
NDA |
IMIPRAMINE PAMOATE |
CAPSULE;ORAL |
EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
1973/03/11
|
Approved Prior to Jan 1, 1982
|
SPECGX LLC |
Discontinued |
TOFRANIL-PM |
017090 |
003 |
NDA |
IMIPRAMINE PAMOATE |
CAPSULE;ORAL |
EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
1973/03/11
|
Approved Prior to Jan 1, 1982
|
SPECGX LLC |
Discontinued |
TOFRANIL-PM |
017090 |
004 |
NDA |
IMIPRAMINE PAMOATE |
CAPSULE;ORAL |
EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
1973/03/11
|
Approved Prior to Jan 1, 1982
|
SPECGX LLC |
Discontinued |